Howard Gross
Director · Wright State University Boonshoft School of Medicine
Credentials: · · · ·
History
- 1979–1981
Medical Oncology
- 1976–1979
Internal Medicine
Research
Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer
Journal of the National Cancer Institute · 1993 · 510 citations
Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma
Journal of Clinical Oncology · 2005 · 424 citations
Journal of Clinical Oncology · 2012 · 422 citations
- EM
8 papers
8 papers
- AB
7 papers
- LF
7 papers
- SD
7 papers
6 papers
6 papers
- SS
6 papers
Grants
- 2014–2027
Dayton Clinical Oncology Program
National Cancer Institute · UG1
Contact PI · $10.7M · Dayton Clinical Oncology Program
- 1983–2014
Dayton Clinical Oncology Program
National Cancer Institute · U10
Contact PI · $14.1M · Dayton Clinical Oncology Program